Digital imaging system for glaucoma given go-ahead in the US
This article was originally published in Clinica
Executive Summary
UK company Marcher Enterprises has received 510(k) marketing clearance in the US for a new non-invasive, digital imaging system used to detect the early onset of glaucoma. The Discam system uses a technique called optic nerve head analysis which measures changes to the nerve head, an early indicator of the condition.